Invenomic Capital Management LP
About Invenomic Capital Management LP’s 13F portfolio
Invenomic Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Invenomic Capital Management LP reported $1.7B across 115 US-listed positions (). Its largest position is GLOBAL PMTS INC (GPN) at 3.8% of the reported book, and its ten biggest holdings make up 29% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: GPN GLOBAL PMTS INC | — — | 3.8% | 882K | $64.0M |
| 2 | NYSE: UHS UNIVERSAL HLTH SVCS INC | — — | 3.8% | 427K | $63.5M |
| 3 | NASDAQ: WDAY WORKDAY INC | — — | 3.5% | 476K | $58.3M |
| 4 | NASDAQ: XRAY DENTSPLY SIRONA INC | — — | 3.1% | 4.9M | $52.1M |
| 5 | NASDAQ: SPSC SPS COMM INC | — — | 3.0% | 869K | $49.7M |
| 6 | NYSE: PVH PVH CORPORATION | — — | 2.6% | 575K | $42.7M |
| 7 | NYSE: BDX BECTON DICKINSON & CO | — — | 2.5% | 273K | $41.3M |
| 8 | NYSE: FIS FIDELITY NATL INFORMATION SV | — — | 2.5% | 1.1M | $41.2M |
| 9 | NASDAQ: CHTR CHARTER COMMUNICATIONS INC | — — | 2.4% | 282K | $40.2M |
| 10 | NYSE: EGO ELDORADO GOLD CORP NEW | — — | 2.2% | 1.2M | $36.0M |
| 11 | NYSE: OMC OMNICOM GROUP INC | — — | 2.1% | 479K | $34.9M |
| 12 | NASDAQ: LYFT LYFT INC | — — | 2.1% | 2.4M | $34.3M |
| 13 | NYSE: BILL BILL HOLDINGS INC | — — | 2.0% | 909K | $32.9M |
| 14 | NYSE: CLVT CLARIVATE PLC | — — | 1.8% | 14.3M | $30.8M |
| 15 | NYSE: CRM SALESFORCE INC | — — | 1.8% | 193K | $30.3M |
| 16 | NYSE: INGM INGRAM MICRO HLDG CORP | — — | 1.8% | 1.1M | $29.6M |
| 17 | NASDAQ: INTU INTUIT | — — | 1.7% | 107K | $27.8M |
| 18 | NASDAQ: VTRS VIATRIS INC | — — | 1.6% | 1.7M | $27.6M |
| 19 | NYSE: CNMD CONMED CORP | — — | 1.6% | 842K | $27.6M |
| 20 | NYSE: OC OWENS CORNING NEW | — — | 1.5% | 161K | $25.5M |
| 21 | NASDAQ: FISV FISERV INC | — — | 1.5% | 520K | $25.5M |
| 22 | NYSE: SON SONOCO PRODS CO | — — | 1.5% | 438K | $24.7M |
| 23 | NYSE: ABM ABM INDS INC | — — | 1.4% | 532K | $23.5M |
| 24 | NYSE: NOMD NOMAD FOODS LTD | — — | 1.4% | 2.1M | $22.9M |
| 25 | NYSE: ST SENSATA TECHNOLOGIES HLDG PL | — — | 1.3% | 470K | $22.4M |
Showing 1–25 of 115 positions on this page reported in this 13F.
- Technology32%
- Healthcare19%
- Industrials14%
- Consumer Cyclical10%
- Communication Services8.0%
- Consumer Defensive7.4%
- Basic Materials3.9%
- Financial Services2.8%
- Real Estate0.4%
- Utilities0.4%
- AddedUHSUNIVERSAL HLTH SVCS INC+131%$63.5M
- AddedXRAYDENTSPLY SIRONA INC+11.8%$52.1M
- AddedSPSCSPS COMM INC+229%$49.7M
- NewBDXBECTON DICKINSON & CO—$41.3M
- AddedFISFIDELITY NATL INFORMATION SV+2.6%$41.2M
- NewCHTRCHARTER COMMUNICATIONS INC—$40.2M
- AddedOMCOMNICOM GROUP INC+7.2%$34.9M
- AddedCLVTCLARIVATE PLC+7.1%$30.8M
- NewINTUINTUIT—$27.8M
- AddedNOMDNOMAD FOODS LTD+6.9%$22.9M
- ReducedGPNGLOBAL PMTS INC−3.6%$64.0M
- ReducedWDAYWORKDAY INC−15.0%$58.3M
- ReducedPVHPVH CORPORATION−24.6%$42.7M
- ReducedEGOELDORADO GOLD CORP NEW−19.3%$36.0M
- ReducedLYFTLYFT INC−19.7%$34.3M
- ReducedBILLBILL HOLDINGS INC−12.1%$32.9M
- ReducedCRMSALESFORCE INC−13.5%$30.3M
- ReducedINGMINGRAM MICRO HLDG CORP−21.9%$29.6M
- ReducedVTRSVIATRIS INC−46.2%$27.6M
- ReducedCNMDCONMED CORP−9.9%$27.6M
Reading Invenomic Capital Management LP’s 13F portfolio
Invenomic Capital Management LP’s $1.7B 13F book is spread across 115 reported positions and is moderately diversified, the ten largest names accounting for 29%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are GPN, UHS, WDAY, XRAY and SPSC, led by GLOBAL PMTS INC (GPN) at 3.8% of the portfolio. The heaviest sector exposure is Technology (32%), then Healthcare (19%).
What Invenomic Capital Management LP changed last quarter
Between 2026-03-31 and Q2 2026, Invenomic Capital Management LP was a net seller: it opened 21 new positions and added to 23 more, while trimming 68 and closing 54 outright. Against a 115-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was UNIVERSAL HLTH SVCS INC (UHS), and its biggest reduction was GLOBAL PMTS INC (GPN).
What a 13F does and doesn’t reveal
A 13F captures only Invenomic Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Invenomic Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Invenomic Capital Management LP's profile on this page is built directly from those filings.
How current is the 13F data on Invenomic Capital Management LP's page?
It reflects Invenomic Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Invenomic Capital Management LP files its next quarterly report, this page refreshes automatically.
Can I see Invenomic Capital Management LP's complete list of holdings?
This page highlights Invenomic Capital Management LP's largest positions rather than all 115 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Invenomic Capital Management LP's filings.
Does a 13F show everything Invenomic Capital Management LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Invenomic Capital Management LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Invenomic Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

